تقرير
Meningococcal disease in the Netherlands. Background information for the Health Council ; Meningokokkenziekte in Nederland : Achtergrondinformatie voor de Gezondheidsraad
| العنوان: | Meningococcal disease in the Netherlands. Background information for the Health Council ; Meningokokkenziekte in Nederland : Achtergrondinformatie voor de Gezondheidsraad |
|---|---|
| المؤلفون: | Knol MJ, de Melker HE, Berbers GAM, Ravenhorst MB, Ruijs WLM, van Vliet JA, Kemmeren JM, Suijkerbuijk A, van Lier EA, Sanders EAM, van der Ende A |
| المساهمون: | RVP, I&V |
| بيانات النشر: | Rijksinstituut voor Volksgezondheid en Milieu RIVM |
| سنة النشر: | 2017 |
| المجموعة: | National Inst. for Public Health and the Environment, Netherlands (RIVM): Webbased Archive of RIVM Publications (WARP) |
| مصطلحات موضوعية: | meningokok, meningokokkenziekte, vaccinatie, ziektelast, kosteneffectiviteit, veiligheid, acceptatie, invoeringsaspecten, meningococcus, RIVM rapport 2017-0031, meningococcal disease, vaccination, disease burden, cost-effectiveness, safety, acceptance, implementation aspects |
| الوصف: | Meningococcal disease is a very serious infectious disease caused by a bacterium, the meningococcus. There are different types of meningococcus; people become ill mainly from the B, C, W and Y serogroups. Since 2002, vaccination against serogroup C meningococcal disease has been included in the National Immunisation Programme for children of 14 months. As a result, serogroup C meningococcal disease has virtually disappeared. Vaccines against serogroup B have recently become available. In addition, since 2015, there has been a rapid increase in serogroup W meningococcal disease. Multi-component vaccines are available against A, C, W and Y serogroups. Based on these developments, among others, the Health Council will advise the Minister for Health, Welfare and Sport on whether and how the current immunisation programme against meningococcal disease should be adapted. To this end, RIVM has collected background information and recent data on meningococcal disease in the Netherlands. It includes the number of people in the Netherlands who become ill each year, the efficacy and safety of the vaccines, and what the public thinks about vaccination against invasive meningococcal disease. The infection causes a severe medical condition such as meningitis or blood poisoning, which can rapidly develop into shock, frequently causing death. The disease often begins with flu-like symptoms and fever which subsequently worsen very rapidly. The infection is relatively rare in the Netherlands; there are currently 100 to 150 patients a year. Five to ten percent of these patients die despite antibiotics and intensive care. Thirty percent of the patients are left with lifelong impairments such as hearing loss, limb amputation or epilepsy. Meningococcal disease is most common in children under the age of 5, adolescents and the elderly. ; Meningokokkenziekte is een zeer ernstige infectieziekte die veroorzaakt wordt door een bacterie, de meningokok. Er zijn verschillende typen meningokokken; mensen worden vooral ziek van de serogroepen ... |
| نوع الوثيقة: | report |
| اللغة: | English |
| العلاقة: | RIVM report 2017-0031; http://www.rivm.nl/bibliotheek/rapporten/2017-0031.pdfTest; http://hdl.handle.net/10029/620853Test |
| DOI: | 10.21945/RIVM-2017-0031 |
| الإتاحة: | https://doi.org/10.21945/RIVM-2017-0031Test http://hdl.handle.net/10029/620853Test |
| رقم الانضمام: | edsbas.FF08134B |
| قاعدة البيانات: | BASE |
| DOI: | 10.21945/RIVM-2017-0031 |
|---|